FDA Offers Advice on Safe Dosing Practices for Diabetes Medications

FDA Offers Advice on Safe Dosing Practices for Diabetes Medications

The U.S. Food and Drug Administration (FDA) has issued a warning to both patients and healthcare providers regarding dosing errors associated with compounded versions, NOT the genuine manufactured product, of Novo Nordisk’s weight-loss and diabetes drugs,...
Facebook
Instagram